PharmaShots | Incisive News in 3 Shots

Subscribe Now

$977M

AbbVie Licenses Lupin's MALT1 Inhibitor Program- for $977M

AbbVie Licenses Lupin's MALT1 Inhibitor Program- for $977M

December 27, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us